CB-201

N/A

Report date: 2023/01/08 14:04:07

Base Information

Drug NameCB-201
Drug Alias NameCB-201
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionReactive oxygen species modulators
TargetsReactive oxygen species
Therapy Area/IndicationsDiabetes Mellitus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCantabio Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesCantabio Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A